Becton Dickinson and Co BDXB:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
53.60UNCH (UNCH)
Volume
4,506
Close
53.60quote price arrow up+1.01 (+1.92%)
Volume
20,178
52 week range
49.00 - 61.08

...

Loading . . .

KEY STATS

  • Open52.55
  • Day High53.74
  • Day Low52.55
  • Prev Close52.59
  • 52 Week High61.08
  • 52 Week High Date08/05/20
  • 52 Week Low49.00
  • 52 Week Low Date05/27/20
  • Market Cap71,608.51M
  • Shares Out290.56M
  • 10 Day Average Volume0.08M
  • Dividend3.00
  • Dividend Yield5.60%
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/11/2021
  • Div Amount0.75
  • Split Date-
  • Split Factor-

Latest Becton Dickinson and Co News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business...
Vincent Forlenza
Chairman
Thomas Polen
Chairman
Christopher Reidy
Chief Financial Officer
Simon Campion
Executive Vice President
Alexandre Conroy
Executive Vice President
Address
1 Becton Dr
Franklin Lakes, NJ
07417-1815
United States